C-type natriuretic peptide effects on cardiovascular nitric oxide system in spontaneously hypertensive rats

Peptides

Volumn 31, Issue 7, 2010, Pages 1309-1318

  Caniffi, Carolina ^a   Elesgaray, Rosana ^a   Gironacci, Mariela ^b   Arranz, Cristina ^a   Costa, María Ángeles ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Aorta artery; CNP; Heart; Nitric oxide synthase; Spontaneously hypertensive rats

Indexed keywords

ATRIAL NATRIURETIC FACTOR ANTAGONIST; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALMODULIN INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; NATRIURETIC PEPTIDE TYPE C; NEURONAL NITRIC OXIDE SYNTHASE; NITRATE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; HEART; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NITRATE METABOLISM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; TISSUE DISTRIBUTION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; HYPERTENSION; MALE; MYOCARDIUM; NATRIURETIC PEPTIDE, C-TYPE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, INBRED SHR;

RATTUS;

EID: 77952675862     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.03.030     Document Type: Article

References (41)

1. Ahluwalia A., and Hobbs A.J. Endothelium-derived C-type natriuretic peptide: more than just a hyperpolarizing factor. Trends Pharmacol Sci 26 (2005) 162-167
2. Ahluwalia A., MacAllister R.J., and Hobbs A.J. Vascular actions of natriuretic peptides. Basic Res Cardiol 99 (2004) 83-89
3. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem J 357 (2001) 593-615
4. Anand-Srivastava M.B., Sehl P.D., and Lowe D.G. Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase. J Biol Chem 271 (1996) 19324-19329
5. Arejian M., Li Y., and Anand-Srivastava M.B. Nitric oxide attenuates the expression of natriuretic peptide receptor C and associated adenylyl cyclase signaling in aortic vascular smooth muscle cells: role of MAPK. Am J Physiol Heart Circ Physiol 296 6 (2009) H1859-H1867
6. Brunner F., and Wolkart G. Relaxant effect of C-type natriuretic peptide involves endothelium and nitric oxide-cGMP system in rat coronary microvasculature. Cardiovasc Res 51 (2001) 577-584
7. Chauhan S.D., Nilsson H., Ahluwalia A., and Hobbs A.J. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc Natl Acad Sci 100 (2003) 1426-1431
8. Chen H.H., and Burnett Jr. J.C. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol 32 (1998) S22-S28
9. Costa M.A., González Bosc L., Majowicz M., Vidal N.A., Balaszczuk A.M., and Arranz C.T. Atrial natriuretic peptide (ANP) modifies arterial blood pressure through nitric oxide (NO) pathway in rat. Hypertension 35 5 (2000) 1119-1123
10. Costa M.A., Elesgaray R., Caniffi C., Fellet A., and Arranz C. Role of cardiovascular nitric oxide system in C-type natriuretic peptide effects. Biochem Biophys Res Commun 359 (2007) 180-186
11. Costa M.A., Elesgaray R., Caniffi C., Fellet A., Mac Laughlin M., and Arranz C. Role of nitric oxide as a key mediator on cardiovascular actions of atrial natriuretic peptide in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 298 3 (2010) H778-H786
12. Costa M.A., Elesgaray R., Loria A., Balaszczuk A.M., and Arranz C. Atrial natriuretic peptide influence on nitric oxide system in kidney and heart. Regul Pept 118 (2004) 151-157
13. Crabos M., Coste P., Paccalin M., Tariosse L., Daret D., Besse D., et al. Reduce basal NO-mediated dilation and decreased NO-synthase expression in coronary vessels of spontaneously hypertensive rats. J Mol Cell Cardiol 29 (1997) 55-65
14. D'Souza S.P., Davis M., and Baxter G.F. Autocrine and paracrine actions of natriuretic peptides in the heart. Pharmacol Ther 101 (2004) 113-129
15. De Forstermann U., Schmidt H.W., Pollock J.S., Sheng H., Mitchell J.A., Warner T.D., et al. Isoforms of nitric oxide synthase: characterization and purification from different cell types. Biochem Pharmacol 42 (1991) 1849-1857
16. Dubois G. Decreased l-arginine-nitric oxide pathway in cultured myoblasts from spontaneously hypertensive versus normotensive Wistar-Kyoto rats. FEBS 392 (1996) 242-412
17. Elesgaray R., Caniffi C., Rodríguez Ierace D., Visintini Jaime M.F., Fellet A., Arranz C., et al. Signaling cascade that mediates endothelial nitric oxide synthase activation induced by atrial natriuretic peptide. Regul Pept 151 (2008) 130-134
18. Félétou M., and Vanhoutte P.M. Endothelial dysfunction: a multifaceted disorder. Am J Physiol Heart Circ Physiol 291 (2006) H985-H1002
19. Hobbs A., Foster P., Prescott C., Scotland R., and Ahluwalia A. Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide. Circulation 110 (2004) 1231-1235
20. Kan W.H., Hsu J.T., Ba Z.F., Schwacha M.G., Chen J., Choudhry M.A., et al. p38 MAPK-dependent eNOS upregulation is critical for 17β-estradiol-mediated cardioprotection following trauma-hemorrhage. Am J Physiol Heart Circ Physiol 294 (2008) H2627-H2636
21. Kempf T., and Wollert K.C. Nitric oxide and the enigma of cardiac hypertrophy. Bioessays 26 (2004) 608-615
22. Komatsu Y., Itoh, Suga S., Ogawa Y., Hama N., Kishimoto I., et al. Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells. Role of vascular natriuretic peptide system in vascular growth inhibition. Circ Res 78 (1996) 606-614
23. Llorens S., Fernández A.P., and Nava E. Cardiovascular and renal alterations on the nitric oxide pathway in spontaneous hypertension and ageing. Clin Hemorheol Microcirc 37 (2007) 149-156
24. Marcil J., Thibault C., and Anand-Srivastava M.B. Enhanced expression of Gi-protein precedes the development of blood pressure in spontaneously hypertensive rats. J Mol Cell Cardiol 29 (1997) 1009-1022
25. McLay J.S., Chatterjee P.K., Jardine A.G., and Hawksworth G.M. Atrial natriuretic factor modulates nitric oxide production: an ANF-C receptor-mediated effect. J Hypertension 13 (1995) 625-630
26. Mount P.F., Kemp B.E., and Power D.A. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 42 (2007) 271-279
27. Murthy K.S., Teng B.Q., Zhou H., Jin J.G., Grider J.R., and Makhlouf G.M. Gi-1/Gi-2-dependent signaling by single-transmembrane natriuretic peptide clearance receptor. Am J Physiol Gastrointest Liver Physiol 278 (2000) G974-G980
28. Nakai K., Yoneda K., Moriue T., Igarashi J., Kosaka H., and Kubota Y. HB-EGF-induced VEGF production and eNOS activation depend on both PI3 kinase and MAP kinase in HaCaT cells. J Dermatol Sci 55 (2009) 170-178
29. Nishikimi T., Maeda N., and Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovasc Res 69 (2006) 318-328
30. Pandey K.N. Biology of natriuretic peptides and their receptors. Peptides 26 (2005) 901-932
31. Peng X., Haldar S., Deshpande S., Irani K., and Kass D.A. Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium. Hypertension 41 (2003) 378-381
32. Piech A., Dessy C., Havaux X., Feron F., and Balligand J.L. Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats. Cardiovasc Res 57 (2003) 456-467
33. Potter L.R., Abbey-Hosch S., and Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27 (2006) 47-72
34. Sabbatini M.E., Vatta M., Davio C., and Bianciotti L. Am J Physiol Gastrointest Liver Physiol 292 (2007) 349-357
35. Simon A., Harrington E.O., Liu G.X., Koren G., and Choudhary G. Mechanism of C-type natriuretic peptide-induced endothelial cell hyperpolarization. Am J Physiol Lung Cell Mol Physiol 296 (2009) L248-L256
36. Tokudome T., Horio T., Soeki T., Mori K., Kishimoto K., Suga S., et al. Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and Endothelin-1 signaling pathways. Endocrinology 145 (2004) 2131-2140
37. Vapaatalo H., Mervaala E., and Nurminen M.L. Role of endothelium and nitric oxide in experimental hypertension. Physiol Res 49 (2000) 1-10
38. Vaziri N.D., Ni Z., and Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 31 (1998) 1248-1254
39. + when the Griess reaction is used to assay for nitrite. Anal Biochem 224 (1995) 502-508
40. Wilkins M.R., Redondo J., and Brown L.A. The natriuretic peptide family. Lancet 349 (1997) 1307-1310
41. Woodard G.E., and Rosado J.A. Natriuretic peptides in vascular physiology and pathology. Int Rev Cell Mol Biol 268 (2008) 59-93